Palo Alto, California, United States Related Funds
| Fund Name | Location |
| Bas-Saint-Laurent | - |
| Dayiwang | Beijing, Beijing, China |
| eumo | Japan, Tokyo |
| Florida Venture Forum | Florida, Tampa, United States |
| Hillfarrance Venture Capital | - |
| Hong Kong Yihe | China, Hong Kong, Hong Kong Island |
| Huaou Dongrong | China, Ningbo, Zhejiang |
| Hubei Qianyong Touzi | China, Hubei, Wuhan |
| Hyundai Venture Investment Corporation | Seoul, Seoul-t'ukpyolsi, South Korea |
| I-Vent | - |
| Lava Trading | Charleston, South Carolina, United States |
| Liberty Satellite & Technology | Colorado, Englewood, United States |
| LinX Corporation | California, Carlsbad, United States |
| Netcetera AG | Switzerland, Zürich, Zurich |
| Palm Beach Capital | Florida, United States, West Palm Beach |
| Pharmstandard International | - |
| Rich Capital | Beijing, China, Haidian |
| Scale Asia Ventures | California, Menlo Park, United States |
| Taurus Value Creation | - |
| Vietnam Investments Groups | Cho Lon, Vietnam |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Xealth | $25M | 05 Oct 2021 | Seattle, Washington, United States | ||
AristaMD | $18M | 31 Mar 2020 | San Diego, California, United States |
– Xealth, the leader in enabling digital health at scale, announced that the company has secured $24 million in Series B funding led by Advocate Aurora Enterprises, a subsidiary of Advocate Aurora Health.
– Seven additional health systems – Banner Health, ChristianaCare, Cone Health, Memorial Hermann, Nebraska Medicine, Novant Health and Stanford Health Care – join existing health system investors Atrium Health, Cleveland Clinic, Froedtert & MCW Health Network, MemorialCare Innovation Fund, Providence and UPMC.
– This brings the company’s total funding to date to $52.6 million.
– Use of digital therapeutics and remote patient monitoring is accelerating as they help fill a necessary role in extending care options for patients.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Xealth | $25M | 05 Oct 2021 | Seattle, Washington, United States | ||
AristaMD | $18M | 31 Mar 2020 | San Diego, California, United States |
